β3-Adrenoceptor Control the Cystic Fibrosis Transmembrane Conductance Regulator through a cAMP/Protein Kinase A-independent Pathway
Open Access
- 1 March 1999
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 274 (10) , 6107-6113
- https://doi.org/10.1074/jbc.274.10.6107
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle.Journal of Clinical Investigation, 1998
- STRUCTURE AND FUNCTION OF THE β3-ADRENERGIC RECEPTORAnnual Review of Pharmacology and Toxicology, 1997
- Human immortalized brown adipocytes express functional β3-adrenoceptor coupled to lipolysisJournal of Cell Science, 1997
- Functional beta3-adrenoceptor in the human heart.Journal of Clinical Investigation, 1996
- Differential interaction of β1- and β3-adrenergic receptors with Gi in rat adipocytesCellular Signalling, 1994
- Molecular cloning of a human β3‐adrenergic receptor cDNAFEBS Letters, 1993
- The promoter and intron/exon structure of the human and mouse β3‐adrenergic‐receptor genesEuropean Journal of Biochemistry, 1993
- Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR)Cell, 1992
- Differences in functional cyclic AMP compartments mediating lepolysis by isoprenaline and BRL 37344 in four adipocyte typesEuropean Journal of Pharmacology, 1991
- Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNAScience, 1989